JAK inhibition for treatment of psoriatic arthritis in Down syndrome

Rheumatology (Oxford). 2021 Sep 1;60(9):e309-e311. doi: 10.1093/rheumatology/keab203.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Arthritis, Psoriatic / drug therapy*
  • Arthritis, Psoriatic / immunology*
  • Down Syndrome / immunology*
  • Female
  • Humans
  • Janus Kinase Inhibitors / administration & dosage*
  • Piperidines / administration & dosage*
  • Pyrimidines / administration & dosage*

Substances

  • Janus Kinase Inhibitors
  • Piperidines
  • Pyrimidines
  • tofacitinib